High-dose ulinastatin to prevent late-onset acute renal failure after orthotopic liver transplantation

References

• Cabezuelo JB, Ramirez P, Rios A, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69(6):1073–1080.
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Thuluvath AJ, Hanish S, et al. Liver transplantation in patients with multiple organ failures: feasibility and outcomes. J Hepatol. 2018;69(5):1047–1056.
   PubMed Web of Science ®Google Scholar
• Mueller AR, Platz KP, Krause P, et al. Perioperative factors influencing patient outcome after liver transplantation. Transpl Int. 2000;13 (Suppl 1):S158–S161.
   PubMedGoogle Scholar
• Chen CC, Liu ZM, Wang HH, He W, et al. Effects of ulinastatin on renal ischemia-reperfusion injury in rats. Acta Pharmacologica Sinica. 2004;25(10):1334–1340.
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez N, Lavilla FJ, Rocha E, et al. Assessment of haemostatic risk factors in patients with acute renal failure associated with severe systemic inflammatory response syndrome. Development of a prognostic index. Nephron. 2002;92(1):97–104.
   PubMed Web of Science ®Google Scholar
• McCaffrey J, Dhakal AK, Milford DV, et al. Recent developments in the detection and management of acute kidney injury. Arch Dis Child. 2017;102(1):91–96.
   PubMed Web of Science ®Google Scholar
• Muramatu M, Mori S, Matsuzawa Y, et al. Purification and characterization of urinary trypsin inhibitor, UTI68, from normal human urine, and its cleavage by human uropepsin. J Biochem. 1980;88(5):1317–1329.
   PubMed Web of Science ®Google Scholar
• Honore PM, Spapen HD. Ulinastatin to prevent acute kidney injury after cardiopulmonary bypass surgery: does serum creatinine tell the whole story? Crit Care. 2016;20(1):183.
   PubMedGoogle Scholar
• Lee B, Lee SY, Kim NY, et al. Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial. Surg Endosc. 2017;31(9):3728–3736.
   PubMed Web of Science ®Google Scholar
• Pang XY, Fang CC, Chen YY, Liu K, et al. Effects of ulinastatin on perioperative inflammatory response and pulmonary function in cardiopulmonary bypass patients. Am J Ther. 2016;23(6):e1680–e1689.
   PubMed Web of Science ®Google Scholar
• Chen Q, Hu C, Liu Y, et al. Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: a randomized, double-blind, placebo-controlled, ascending-dose study. PloS One. 2017;12(5):e0177425.
   PubMed Web of Science ®Google Scholar
• Rhee KY, Sung TY, Kim JD, et al. High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: a retrospective study. J Int Med Res. 2018;46(3):1238–1248.
   PubMed Web of Science ®Google Scholar
• Xu CE, Zou CW, Zhang MY, et al. Effects of high-dose ulinastatin on inflammatory response and pulmonary function in patients with type-A aortic dissection after cardiopulmonary bypass under deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 2013;27(3):479–484.
   PubMed Web of Science ®Google Scholar
• Karnad DR, Bhadade R, Verma PK, et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med. 2014;40(6):830–838.
   PubMed Web of Science ®Google Scholar
• Li XY, Guan JQ, Shen N, et al. Protective effects of ulinastatin during orthotopic liver transplantation on kidney function with decreasing acute renal failure after liver transplantation in patients with severe hepatitis. Zhonghua yi Xue za Zhi. 2010;90(5):315–318.
   PubMedGoogle Scholar
• World Health O. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation. 2010;90(3):229–233.
   PubMed Web of Science ®Google Scholar
•  The Regulation on Human Organ Transplantation [Internet]. State Council of the People’s Republic of China; 2007. Available from: http://www.gov.cn/flfg/2007-04/06/content_575602.htm
   Google Scholar
•  The Interim Provisions on Human Organ Procurement and Allocation. Beijing: National Health and Family Planning Commission; 2013. Available from: http://www.gov.cn/jrzg/2013-08/21/content_2471265.htm
   Google Scholar
• Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth. 2000;85(3):487–491.
   PubMed Web of Science ®Google Scholar
• Brecher ME, Monk T, Goodnough LT. A standardized method for calculating blood loss. Transfusion. 1997;37(10):1070–1074.
   PubMed Web of Science ®Google Scholar
• Yuasa T, Niwa N, Kimura S, et al. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion. 2005;45(6):879–884.
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–184.
   PubMedGoogle Scholar
• Barreto AG, Daher EF, Silva GB Jr, et al. Risk factors for acute kidney injury and 30-day mortality after liver transplantation. Ann Hepatol. 2015;14(5):688–694.
   PubMed Web of Science ®Google Scholar
• Coulthard MG. The management of neonatal acute and chronic renal failure: a review. Early Hum Dev. 2016;102:25–29.
   PubMed Web of Science ®Google Scholar
• Bastos-Neves D, Salvalaggio PRO, Almeida MD. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction. Hepatobiliary Pancreat Dis Int. 2019;18(5):423–429.
   PubMed Web of Science ®Google Scholar
• Smoter P, Nyckowski P, Grat M, et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. Transplant Proc. 2014;46(8):2786–2789.
   PubMed Web of Science ®Google Scholar
• Luo GJ, Yao WF, He Y, et al. Ulinastatin prevents acute lung injury led by liver transplantation. J Surg Res. 2015;193(2):841–848.
   PubMed Web of Science ®Google Scholar
• Jiang W, Yu X, Sun T, et al.; for the China Critical Care Clinical Trials Group (CCCCTG). ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial. Trials. 2018;19(1):133.
   PubMedGoogle Scholar
• Liu Y, Wu XH. Effect of ulinastatin on serum levels of tumor necrosis factor-alpha, P-selectin, and thrombin-antithrombin complex in young rats with sepsis. Zhongguo Dang Dai er ke za Zhi. 2017;19(2):237–241.
   PubMedGoogle Scholar
• Ji Z, Tian H, Shang J, et al. Effect of different doses of ulinastatin on cellular immunity and hepatorenal functions in patients undergoing laparoscopic colorectalcarcinoma surgery. Pak J Pharm Sci. 2018;31(5 (Special)):2311–2314.
   PubMed Web of Science ®Google Scholar
• Basile DP, Bonventre JV, Mehta R, et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. JASN. 2016;27(3):687–697.
   Web of Science ®Google Scholar
• Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43(6):855–866.
   PubMed Web of Science ®Google Scholar
• Devarajan P. Acute kidney injury: acute kidney injury: still misunderstood and misdiagnosed. Nat Rev Nephrol. 2017;13(3):137–138.
   PubMed Web of Science ®Google Scholar
• Chew ST, Ng RR, Liu W, et al. Acute kidney injury increases the risk of end-stage renal disease after cardiac surgery in an Asian population: a prospective cohort study. BMC Nephrol. 2017;18(1):60.
   PubMedGoogle Scholar
• Kellum JA, Sileanu FE, Bihorac A, et al. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784–791.
   PubMed Web of Science ®Google Scholar